These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15090455)

  • 1. Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation.
    Holler E; Rogler G; Herfarth H; Brenmoehl J; Wild PJ; Hahn J; Eissner G; Schölmerich J; Andreesen R
    Blood; 2004 Aug; 104(3):889-94. PubMed ID: 15090455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation.
    Granell M; Urbano-Ispizua A; Aróstegui JI; Fernández-Avilés F; Martínez C; Rovira M; Rius J; Plaza S; Gaya A; Navarro A; Talarn C; Carreras E; Monzó M; Montserrat E; Yagüe J
    Haematologica; 2006 Oct; 91(10):1372-6. PubMed ID: 17018387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recipient NOD2/CARD15 variants: a novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation.
    Hildebrandt GC; Granell M; Urbano-Ispizua A; Wolff D; Hertenstein B; Greinix HT; Brenmoehl J; Schulz C; Dickinson AM; Hahn J; Rogler G; Andreesen R; Holler E
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):67-74. PubMed ID: 18158963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.
    Jaskula E; Lange A; Kyrcz-Krzemien S; Markiewicz M; Dzierzak-Mietla M; Jedrzejczak WW; Czajka P; Mordak-Domagala M; Lange J; Gronkowska A; Nowak J; Warzocha K; Hellmann A; Kowalczyk J; Drabko K; Gozdzik J; Mizia S;
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):409-14. PubMed ID: 24345423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination.
    Holler E; Rogler G; Brenmoehl J; Hahn J; Herfarth H; Greinix H; Dickinson AM; Socié G; Wolff D; Fischer G; Jackson G; Rocha V; Steiner B; Eissner G; Marienhagen J; Schoelmerich J; Andreesen R
    Blood; 2006 May; 107(10):4189-93. PubMed ID: 16424393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation.
    Nguyen Y; Al-Lehibi A; Gorbe E; Li E; Haagenson M; Wang T; Spellman S; Lee SJ; Davidson NO
    Blood; 2010 Apr; 115(17):3625-31. PubMed ID: 20177049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation.
    Holler E; Rogler G; Brenmoehl J; Hahn J; Greinix H; Dickinson AM; Socie G; Wolff D; Finke J; Fischer G; Jackson G; Rocha V; Hilgendorf I; Eissner G; Marienhagen J; Andreesen R
    Int J Immunogenet; 2008 Aug; 35(4-5):381-4. PubMed ID: 18976442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOD2/CARD15 variants are not a risk factor for clinical outcome after nonmyeloablative allogeneic stem cell transplantation.
    van der Straaten HM; Paquay MM; Tilanus MG; van Geloven N; Verdonck LF; Huisman C
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1231-6. PubMed ID: 21215810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No impact of NOD2/CARD15 on outcome after SCT.
    Sairafi D; Uzunel M; Remberger M; Ringdén O; Mattsson J
    Bone Marrow Transplant; 2008 Jun; 41(11):961-4. PubMed ID: 18317454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children.
    Gruhn B; Intek J; Pfaffendorf N; Zell R; Corbacioglu S; Zintl F; Beck JF; Debatin KM; Steinbach D
    Biol Blood Marrow Transplant; 2009 Dec; 15(12):1571-7. PubMed ID: 19896081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation.
    Elmaagacli AH; Koldehoff M; Hindahl H; Steckel NK; Trenschel R; Peceny R; Ottinger H; Rath PM; Ross RS; Roggendorf M; Grosse-Wilde H; Beelen DW
    Transplantation; 2006 Jan; 81(2):247-54. PubMed ID: 16436969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recipient NOD2/CARD15 status affects cellular infiltrates in human intestinal graft-versus-host disease.
    Landfried K; Bataille F; Rogler G; Brenmoehl J; Kosovac K; Wolff D; Hilgendorf I; Hahn J; Edinger M; Hoffmann P; Obermeier F; Schoelmerich J; Andreesen R; Holler E
    Clin Exp Immunol; 2010 Jan; 159(1):87-92. PubMed ID: 19912254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms within epithelial receptors: NOD2/CARD15.
    Brenmoehl J; Holler E; Rogler G
    Methods Mol Med; 2007; 134():115-22. PubMed ID: 17666747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple single-nucleotide polymorphism-based risk model for clinical outcomes after allogeneic stem-cell transplantation, especially for acute graft-versus-host disease.
    Kim DD; Yun J; Won HH; Cheng L; Su J; Xu W; Uhm J; Gupta V; Kuruvilla J; Messner HA; Lipton JH
    Transplantation; 2012 Dec; 94(12):1250-7. PubMed ID: 23169244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors.
    Mayor NP; Shaw BE; Hughes DA; Maldonado-Torres H; Madrigal JA; Keshav S; Marsh SG
    J Clin Oncol; 2007 Sep; 25(27):4262-9. PubMed ID: 17724347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD31 mismatching affects marrow transplantation outcome.
    Grumet FC; Hiraki DD; Brown BWM ; Zehnder JL; Zacks ES; Draksharapu A; Parnes J; Negrin RS
    Biol Blood Marrow Transplant; 2001; 7(9):503-12. PubMed ID: 11669217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation.
    van der Velden WJ; Blijlevens NM; Maas FM; Schaap NP; Jansen JH; van der Reijden BA; Feuth T; Dolstra H; Donnelly JP
    Bone Marrow Transplant; 2009 Aug; 44(4):243-8. PubMed ID: 19219079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variations of interleukin-23R (1143A>G) and BPI (A645G), but not of NOD2, are associated with acute graft-versus-host disease after allogeneic transplantation.
    Wermke M; Maiwald S; Schmelz R; Thiede C; Schetelig J; Ehninger G; Bornhäuser M; Wassmuth R
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1718-27. PubMed ID: 20541026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants in the NOD2/CARD15 gene are associated with early mortality in sepsis patients.
    Brenmoehl J; Herfarth H; Glück T; Audebert F; Barlage S; Schmitz G; Froehlich D; Schreiber S; Hampe J; Schölmerich J; Holler E; Rogler G
    Intensive Care Med; 2007 Sep; 33(9):1541-8. PubMed ID: 17558494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.